BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 23, 2003
View Archived Issues
Alcon claims three series of 5-HT2 agonists with utility in glaucoma therapy
Read More
Researchers report production of fully active antibodies in algae chloroplasts
Read More
Novel series of erythromycin analogues designed at Pfizer
Read More
Uniroyal researchers identify novel antiretroviral agents for HIV and HCMV infections
Read More
Water-soluble antifungal compounds covered by Sankyo patent
Read More
Novel antagonists of platelet ADP (P2YAC) receptors discovered at Schering AG
Read More
Celera patent covers the preparation and use of new cathepsin S inhibitors
Read More
Scientists at Boehringer Ingelheim present novel tachykinin antagonists and their uses
Read More
Hynic-Annexin V IND withdrawn, to be resubmitted at later date
Read More
AxCell Biosciences and Celgene team up for ubiquitin ligase research
Read More
ALT-711 reduces left ventricular mass in DIAMOND trial
Read More
Asmanex Twisthaler launched in U.K.
Read More
Lamictal approved for adjunctive use in pediatric partial seizures
Read More
Coley earns CpG-7279 milestone payment from Aventis
Read More
Phase I study initiated for P-63
Read More
RK-0202 enters phase II evaluation in oral mucositis
Read More
Inhale Therapeutic Systems becomes Nektar Therapeutics
Read More
IPD-1151T licensed to Yamanouchi for global development in cystitis and prostatitis
Read More
Inhibition of endogenous cannabinoid breakdown as a novel antianxiety strategy
Read More
Yamanouchi team discovers new antifungal antibiotic with novel mechanism
Read More
Novartis stops development of DRF-4158 but continues collaboration with Dr. Reddy's
Read More
Efficacy of TAK-427 in experimental model of atopic dermatitis
Read More
